A Randomized Controlled Clinical Trial to Evaluate the Efficacy, Safety, Cost-Effectiveness and Effect on PAI-1 Levels of the Three Low-Molecular-Weight Heparins – Enoxaparin, Nadroparin and Dalteparin
2016 ◽
Vol 45
◽
pp. 74
◽
2017 ◽
Vol 97
(4)
◽
pp. 1120-1126
◽
2018 ◽
Vol 33
(S1)
◽
pp. 61-62
2013 ◽
Vol 42
(4)
◽
pp. 366-374
◽
2003 ◽
Vol 17
(1)
◽
pp. 24-28
◽